CME Group Inc. (NASDAQ:CME) reported an EPS of $2.52, beating the estimated $2.46.
The company’s revenue reached approximately $1.53 billion, exceeding expectations and marking a 4.2% year-over-year increase.
CME’s financial health is solid, with a low debt-to-equity ratio of 0.12 and a stable current ratio of 1.02.
CME Group Inc. (NASDAQ:CME) is a leading derivatives marketplace, specializing in options and futures trading. The company offers a wide range of global benchmark products across various asset classes, including interest rates, equity indices, and commodities. Despite facing competitive and regulatory challenges, CME continues to thrive with its extensive portfolio and robust clearing services.
On February 12, 2025, CME reported impressive earnings per share (EPS) of $2.52, surpassing the estimated $2.46. This marks a significant improvement from the $2.37 EPS reported in the same quarter last year. The earnings surprise for this quarter stands at 3.28%, as highlighted by Zacks. Over the past four quarters, CME has consistently outperformed consensus EPS estimates, demonstrating its strong financial performance.
CME also reported actual revenue of approximately $1.53 billion, exceeding the estimated $1.51 billion. This represents a 4.2% increase compared to the previous year, as noted by Zacks. The company has successfully surpassed consensus revenue estimates in each of the last four quarters, showcasing its ability to generate consistent growth in a competitive industry.
The company’s financial health is further supported by its valuation metrics. CME has a price-to-earnings (P/E) ratio of approximately 26.22, indicating the market’s valuation of its earnings. Its price-to-sales ratio stands at about 14.93, reflecting the market’s valuation of its revenue. Additionally, CME’s enterprise value to sales ratio is around 15.11, and its enterprise value to operating cash flow ratio is approximately 24.58, providing insights into its valuation relative to sales and cash flow.
CME maintains a relatively low level of debt compared to its equity, with a debt-to-equity ratio of 0.12. The current ratio of 1.02 suggests that CME has a balanced level of current assets to cover its current liabilities. These financial metrics indicate a stable financial position, allowing CME to continue its growth trajectory in the derivatives marketplace.
